ABN AMRO Bank N.V.

Bank

Position in ABBV — AbbVie Inc.

CIK 1561082 AMSTERDAM, P7

Position in ABBV

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$187,995,963

-$20,812,593 QoQ

Shares Held

864,389

-5.4% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

2.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ABN AMRO Bank N.V. holds $948,098,619 across 8 Drug Manufacturers - General names. ABBV ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,445,171	$482,236,624
2	LLY	ELI LILLY & Co	239,700	$220,468,869
3	ABBV	AbbVie Inc. This page	864,389	$187,995,963
4	GILD	Gilead Sciences, Inc.	195,724	$27,278,053
5	MRK	Merck & Co., Inc.	147,377	$17,727,979
6	JNJ	Johnson & Johnson	37,023	$9,049,902
7	AMGN	Amgen Inc	5,506	$1,937,286
8	PFE	Pfizer Inc	49,998	$1,403,943

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$187,995,963	864,389	-5.4%	Shares	Sole	2026-04-22
2025-12-31	$208,808,556	913,863	-2.1%	Shares	Sole	2026-02-04
2025-09-30	$216,044,185	933,075	+1.0%	Shares	Sole	2025-11-05
2025-06-30	$171,510,652	923,988	+0.7%	Shares	Sole	2025-08-12
2025-03-31	$192,187,877	917,277	-9.2%	Shares	Sole	2025-08-28
2024-12-31	$179,557,320	1,010,452	-13.2%	Shares	Sole	2025-08-28
2024-09-30	$229,993,699	1,164,643	+1.4%	Shares	Sole	2025-08-28
2024-06-30	$197,009,072	1,148,607	+0.4%	Shares	Sole	2025-08-28
2024-03-31	$208,351,171	1,144,158	+15303.3%	Shares	Sole	2025-08-28
2023-12-31	$1,151,117	7,428	-27.0%	Shares	Sole	2025-08-28
2023-09-30	$1,515,940	10,170	-29.8%	Shares	Sole	2025-08-28
2023-06-30	$1,950,890	14,480	-20.7%	Shares	Sole	2025-08-28
2023-03-31	$2,908,661	18,251	—	Shares	Sole	2025-08-28
No filing history on record for this holder in this stock.